Air Sof published presentations and documents on DocSlides.
400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...
400/100 mg . qd. N = 500. N = 100. W12. Placebo. ...
400/100/100 mg QD. N = 501. N = 440. W8. SOF/VEL ...
N = 69. >. 18 years. Failure to SOF/VEL . or ...
N = 12. N = 13. W24. W16. SOF + EBR + GZR + RBV. ...
in genotypes 1 or 3, with or without cirrhosis. &...
Open-label. Chronic HCV infection. Genotype 1 . F...
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
in genotypes 1 or 3, with or without cirrhosis. &...
400/100/100 mg QD. N = 263. N = 152. W12. Placebo...
Randomisation. 1 : 1. 18-70 years. HCV genotype 1...
W24. SOF/VEL. >. 18 years. Chronic HCV infect...
≥ 18 years. Chronic HCV infection. Genotype 1 or...
1. AFSOC Basics. Mission. : . Organize. , train ...
Wargaming Div, MCWL, Quantico. Updated 10 Jan 20...
Director, J6/CIO . United States Special Operatio...
Acquisition Perspective . to. . NDIA. James W. C...
Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...
With Or Without Ribavirin Is Safe and Efficacious...
HCV WORLD CAB . FEBRUARY 2014. BANGKOK, THAI...
qd. + SOF 400 mg . qd. N = 40. W12. 18-70 years....
With Or Without Ribavirin Is Safe and Efficacious...
Design. LDV/SOF. Open-label. ION-4 . Study. : LDV...
qd. Non-randomised. Open-label. N =. 21. W12. SV...
SOF + SMV + RBV. SOF + SMV. Randomisation. 2 : 1 ...
-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...
Enduring ARSOF First Order Problems, the Solution...
This program is s. upported. by educational gran...
). Slide deck prepared . by: . David H. Spach, MD...
Srini Raghavan . Ali Rohani. BRK2077. What does i...
Interim Analysis of a French Multicenter Compassi...
Slides for today’s webinar are available on the...
with Direct-Acting Antivirals (DAAs). www.hcvguide...
Sofosbuvir. . Combo Therapy . Despite . Slow . He...
Outline. Challenges. MEF’s . Third Network Visio...
April 10. –14. , 2019. Vienna, Austria. Disclaim...
. Plus . Sofosbuvir. With or Without Ribavirin . ...
Copyright © 2024 DocSlides. All Rights Reserved